Trials / Unknown
UnknownNCT04574128
Retransfusion or Not of Cardiotomy Blood
Blood Loss With Cardiopulmonary Bypass, Re-transfusion or Not.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Örebro University, Sweden · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomised controlled trial has a non-inferiority design. The aim is to test if the blood loss (volume in mL and hemoglobin) is effected by heart and lung cardiotomy retransfusion, or not? Forty CABG (Coronary Artery By pass Grafting) patients will be allocated to either receive retransfusion (n=20) of cardiotomy blood via the heart and lung mashine, or no retransfusion (n=20).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | No retransfusion of cardiotomy blood | No retransfusion of cardiotomy blood via heart- and lung mashine |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-08-30
- Completion
- 2022-12-30
- First posted
- 2020-10-05
- Last updated
- 2020-10-05
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04574128. Inclusion in this directory is not an endorsement.